Companies: Groove Chocolate Inc., Daniel Chocolates
Issue: Food ? Allergen ? Milk
Category: Candy, confectionary, snacks and sweeteners
What to do: Do not consume recalled products to which you are allergic or sensitive.
Audience: General public
Recall class: Class 1
Affected products
Brand
Product
Size
UPC
Codes
Groove Chocolate
Dark Chocolate 66%
85 g
6 27987 45880 0
020923
Groove
Chocolate
Dark Chocolate 66% with Sea Salt
85 g
6 27987 45882 4
011123
011723
Daniel Chocolates
66% Cocoa Dark Chocolate
85 g
6 28059 00262 4
Best Before 02.09.2023
Issue
The affected products are being recalled from the marketplace because they may contain milk which is not declared on the label.
The recalled products have been sold in Alberta, British Columbia, Manitoba, and Ontario, and may have been distributed in other provinces and territories. They have also been sold online.
What you should do
Check to see if you have recalled products
Do not consume recalled products to which you are allergic or sensitive as they may cause a serious or life-threatening reaction
Do not serve, use, sell or distribute recalled products
Recalled products should be thrown out or returned to the location where they were purchased
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host its VISIONS 2024 conference at the Chicago Marriott Downtown Magnificent Mile on June 21?22, 2024. This biennial...
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new groundbreaking algorithm, SignalHF1, used...
The American Trucking Associations is calling attention to the negative consequences for highway safety and safety-sensitive industries that could result from the U.S. Drug Enforcement Administration's proposal to reschedule marijuana from a Schedule...
- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)- Data to be presented from...
We are advised by OsteoStrong that journalists and other readers should disregard the news release, OsteoStrong Celebrates Success and Innovation at 11th Annual Global Franchise Owner Convention, issued May 9, 2024 over PR Newswire.
SOURCE...
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...